Related by context. Frequent words. (Click for all words.) 73 liposomal formulation 72 Panzem R 72 refractory chronic lymphocytic 71 polymerase inhibitor 70 Pivotal Phase III 70 targeting CD# 70 multi kinase inhibitor 70 Factor VIIa 70 forodesine 70 Initiate Phase 69 proteasome inhibitor 69 orally bioavailable 69 PEG SN# 69 MEK inhibitor 69 Presents Positive 68 humanized anti 68 Ixempra 68 Denufosol 68 Carfilzomib 68 Amrubicin 68 JAK1 68 CCX# 68 relapsed refractory multiple myeloma 68 HCV protease inhibitor 68 mTOR inhibitor 68 humanized monoclonal antibody 68 INCB# [001] 68 KRN# 68 Entereg R 68 Azedra 68 Thiarabine 68 R sorafenib tablets 67 VALSTAR 67 PSN# [002] 67 anticancer compound 67 luteinizing hormone releasing 67 Rebif ® 67 Completes Enrollment 67 Traficet EN 67 Tesetaxel 67 elotuzumab 67 partial agonist 67 pseudobulbar affect PBA 67 romidepsin 66 phase IIb clinical 66 epothilone 66 novel orally administered 66 selective inhibitor 66 inhaled formulation 66 ISTODAX 66 Argatroban 66 TLR9 agonist 66 cutaneous T cell 66 angiogenesis inhibitor 66 diabetic neuropathic pain 66 IIa trial 66 Phase Ib II 66 Phase 2b clinical trials 66 Initiates Phase 66 CIMZIA TM 66 Epratuzumab 66 Shigamabs ® 66 Daclizumab 66 Pivotal Phase 66 Recombinant Human 66 Mipomersen 66 Pivotal Study 66 sunitinib malate 66 Aliskiren 66 injectable formulation 66 6R BH4 65 phase Ib 65 DDP# 65 FDA Accepts 65 HDAC inhibitor 65 castrate resistant prostate cancer 65 subcutaneous formulation 65 Pegasys ® 65 ALN TTR# 65 Clofarabine 65 deforolimus 65 Alzhemed TM 65 MNTX 65 Drug Candidate 65 Dasatinib 65 nicotinic alpha 7 65 KNS # 65 Single Dose 65 Cloretazine R VNP#M 65 Phase 2a clinical 65 Phase III Clinical Trial 65 nitric oxide donating 65 vascular disrupting agent 65 Kuvan R 65 Monoclonal Antibody 65 MKC# 65 Nexavar ® 65 multiple myeloma MM 65 GRNVAC1 65 thymalfasin 65 anti TNF alpha